Trial intelligence / Profile preview

Randomized postoperative cisplatin study in head and neck/oral cancer

2005-000833-39Phase 3Completed

Sponsor
Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano
Start
Oct 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of cisplatin in head and neck cancer (HNC) and mouth neoplasm, sponsored by Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano. Started Oct 2008; status: completed.

02

Drugs

cisplatin
03

Conditions

head and neck cancer (HNC)mouth neoplasm

Beyond the preview

Go deeper on 2005-000833-39.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-000833-39.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call